# A Clinical Study of the Paradise™ Renal Denervation System in Patients With Hypertension (RADIANCE-HTN DUO)

Study · id `cardio:ct-nct05326230` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05326230](<https://clinicaltrials.gov/study/NCT05326230>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05326230

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 154 participants.

## Technical summary

Registry record NCT05326230. Randomized; double masking; primary purpose treatment. Start 2022-07-01 (actual); primary completion 2026-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 154 participants (planned count; ClinicalTrials.gov record NCT05326230, source copy `cardio:ctgov-nct05326230-2026-04-15`, retrieved 2026-10-26)
- Started: 2022-07-01 (actual) (ClinicalTrials.gov record NCT05326230, source copy `cardio:ctgov-nct05326230-2026-04-15`, retrieved 2026-10-26)
- Primary completion: 2026-12 (anticipated) (ClinicalTrials.gov record NCT05326230, source copy `cardio:ctgov-nct05326230-2026-04-15`, retrieved 2026-10-26)
- Completion: 2032-12 (anticipated) (ClinicalTrials.gov record NCT05326230, source copy `cardio:ctgov-nct05326230-2026-04-15`, retrieved 2026-10-26)
- Countries: Japan (ClinicalTrials.gov record NCT05326230, source copy `cardio:ctgov-nct05326230-2026-04-15`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05326230-2026-04-15`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Clinical Study of the Paradise™ Renal Denervation System in Patients With Hypertension (RADIANCE-HTN DUO)
- Condition: Hypertension
- Condition: Vascular Diseases
- Condition: Cardiovascular Diseases
- Intervention (Device): Paradise™ (PRDS-001) Renal Denervation Ultrasound System
- Intervention (Device): Renal Angiogram
- Lead sponsor: Otsuka Medical Devices Co., Ltd. Japan
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)

## Provenance

Content hash: e0696de5e9ae81997e115ea4122156a3d0c43b33a5b30224780fa22abfc7fe1d
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
